» Articles » PMID: 35368005

Histopathological Analysis of Soft Tissue Changes in Gingival Biopsied Specimen from Patients with Underlying Corona Virus Disease Associated Mucormycosis (CAM)

Overview
Specialty Dentistry
Date 2022 Apr 3
PMID 35368005
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Corona Virus Disease-2019 (COVID-19) is perhaps the disastrous medical emergencies that has ever hit globally with multiple strains. Amongst various sequelae, mucormycosis may be considered as the most debilitating one. Post COVID-19 mucormycosis is formally regarded as corona virus disease associated mucormycosis (CAM). The aim of the current paper is to present twelve cases of CAM with unique clinical presentation with a detailed histopathological correlation of the gingival biopsied material.

Material And Methods: Twelve cases of CAM were included in the study who presented initially with non-purulent swelling of the gingiva. The clinic-demographic data pertaining to age, gender, location, laterality and presence of co-morbidities was collected along with histopathological examination of biopsied specimen.

Results: The patients ranged from 31-65 years (mean age 47.33 years). There was a male predominance. Clearly, maxillary right gingiva was mostly affected and all cases presented with non purulent, non tender swelling of the gingiva. The incisional biopsy from the gingiva consistently showed pseudoepitheliomatous hyperplasia of the surface epithelium along with vacuolar degeneration, extensive stromal edema, massive mixed inflammatory reaction, congested blood vessels, hemorrhage and abundant multinucleated giant cells. Potassium hydroxide (10% KOH) mount served no additional diagnostic advantage. After two initial biopsies any suspected case of CAM with these features was treated with appropriate antifungal therapy and conservative excision.

Conclusions: Gingival swelling with aforementioned histopathological features resembling post COVID-19 histological alterations could be alarming early signs of CAM and are candidate of prompt antifungal therapy rather than repeat biopsy for confirmation.

Citing Articles

Resection and Rehabilitation for COVID-19 Associated Rhino-Maxillary Mucormycosis: A Case Report.

Sneha A, Kumar M P S, Krishnan M, Dhasarathan P, O R Muralidoss H Cureus. 2023; 15(5):e39670.

PMID: 37398772 PMC: 10307985. DOI: 10.7759/cureus.39670.


SARS-CoV-2 infection causes periodontal fibrotic pathogenesis through deregulating mitochondrial beta-oxidation.

Gao Y, Kok W, Sharma V, Illsley C, Hanks S, Tredwin C Cell Death Discov. 2023; 9(1):175.

PMID: 37236979 PMC: 10214333. DOI: 10.1038/s41420-023-01474-2.


Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.

Almyroudi M, Akinosoglou K, Rello J, Blot S, Dimopoulos G Diagnostics (Basel). 2022; 12(12).

PMID: 36553099 PMC: 9777018. DOI: 10.3390/diagnostics12123092.

References
1.
Daneshgaran G, Dubin D, Gould D . Cutaneous Manifestations of COVID-19: An Evidence-Based Review. Am J Clin Dermatol. 2020; 21(5):627-639. PMC: 7456663. DOI: 10.1007/s40257-020-00558-4. View

2.
Caramaschi S, Kapp M, Miller S, Eisenberg R, Johnson J, Epperly G . Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review. Mod Pathol. 2021; 34(9):1614-1633. PMC: 8141548. DOI: 10.1038/s41379-021-00814-w. View

3.
Garg D, Muthu V, Sehgal I, Ramachandran R, Kaur H, Bhalla A . Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature. Mycopathologia. 2021; 186(2):289-298. PMC: 7862973. DOI: 10.1007/s11046-021-00528-2. View

4.
Yang M, Chen S, Huang B, Zhong J, Su H, Chen Y . Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications. Eur Urol Focus. 2020; 6(5):1124-1129. PMC: 7261470. DOI: 10.1016/j.euf.2020.05.009. View

5.
Zhao Q, Fang X, Pang Z, Zhang B, Liu H, Zhang F . COVID-19 and cutaneous manifestations: a systematic review. J Eur Acad Dermatol Venereol. 2020; 34(11):2505-2510. PMC: 7361780. DOI: 10.1111/jdv.16778. View